India’s rapid healthcare expansion highlights the urgent need to ensure that growth translates into making healthcare affordable for a larger population
Roche has reaffirmed its full-year guidance, keeping Roche's Growth Story alive despite Vabysmo slowdown sales and ongoing currency headwinds.
The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, reaffirming its position as one of India's leading knowledge
Dr Reddy's API fix has cleared the way for the return of generic semaglutide supplies by November. The company expects production to resume after resolving a quality issue linked to the active pharmaceutical ingredient.
A fresh Trump tariff warning dragged pharma stocks lower on Tuesday. Investors turned cautious after Donald Trump proposed steep duties on imported generic drugs.
The US Cancer Market has moved a step closer for Alembic Pharma and Natco Pharma after the companies secured a key regulatory milestone.
The suspension of Premarin vaginal cream by Pfizer has drawn attention for its immediate impact, and also signals in evolving priorities in the Indian market
The India-UK FTA has sparked a fresh debate across India's pharmaceutical sector. Drugmakers see the agreement as a major export opportunity.
Generic Semaglutide has helped Sun Pharmaceutical Industries expand its global presence with a fresh regulatory win.
The Indian Pharma Industry is moving towards a biosimilars manufacturing growth phase. Earlier this year, India was the subject of a global collaboration that reflects growing international trust in its abilities
, CDSCO.jpg)